NCT05274880

Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393

A Randomized, Open-label, Single Dose, Crossover Study to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-393 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 54 Years
• Healthy volunteers: Accepted

Summary

Study to evaluate the food effect on pharmacokinetic profiles and safety of CKD-393 in healthy volunteers

Detailed description

A randomized, open-label, single dose, crossover study to evaluate the food effect on pharmacokinetic profiles and safety of CKD-393 in healthy volunteers

Conditions

• Type II Diabetes Mellitus

Interventions

Type	Name	Description
DRUG	CKD-393	PO, QD

Timeline

• Start date: 2022-06-21
• Primary completion: 2022-07-15
• Completion: 2022-07-26
• First posted: 2022-03-11
• Last updated: 2022-11-30

Locations

1 site across 1 country: South Korea